BRPI0821456A2 - Partícula similar à pcv2 orf2 com inserção de aminoácido estranho - Google Patents

Partícula similar à pcv2 orf2 com inserção de aminoácido estranho

Info

Publication number: BRPI0821456A2
Authority: BR; Brazil
Prior art keywords: amino acid; acid insertion; pcv2 orf2; foreign amino; particle similar
Prior art date: 2007-12-31

Application number

BRPI0821456-5A

Other languages

English (en)

Inventor

Eric Vaughn

Merrill Schaeffer

Original Assignee

Boehring Ingelheim Vetmedica Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-31

Filing date

2008-12-31

Publication date

2015-06-16

2008-12-31 Application filed by Boehring Ingelheim Vetmedica Inc filed Critical Boehring Ingelheim Vetmedica Inc

2015-06-16 Publication of BRPI0821456A2 publication Critical patent/BRPI0821456A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/012—Coccidia antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

BRPI0821456-5A 2007-12-31 2008-12-31 Partícula similar à pcv2 orf2 com inserção de aminoácido estranho BRPI0821456A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1786307P	2007-12-31	2007-12-31
PCT/US2008/088678 WO2009088950A2 (en)	2007-12-31	2008-12-31	Pcv2 orf2 virus like particle with foreign amino acid insertion

Publications (1)

Publication Number	Publication Date
BRPI0821456A2 true BRPI0821456A2 (pt)	2015-06-16

Family

ID=40853690

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0821456-5A BRPI0821456A2 (pt)	2007-12-31	2008-12-31	Partícula similar à pcv2 orf2 com inserção de aminoácido estranho

Country Status (9)

Country	Link
US (2)	US20110020394A1 (pt)
EP (1)	EP2231182A4 (pt)
JP (1)	JP2011508595A (pt)
KR (1)	KR20100103535A (pt)
CN (1)	CN101932336B (pt)
AU (1)	AU2008347235A1 (pt)
BR (1)	BRPI0821456A2 (pt)
CA (1)	CA2710558A1 (pt)
WO (1)	WO2009088950A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2710558A1 (en) *	2007-12-31	2009-07-16	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 orf2 virus like particle with foreign amino acid insertion
CN101773667A (zh) *	2010-01-28	2010-07-14	洛阳普莱柯生物工程有限公司	一种猪圆环病毒ii型疫苗制备
KR102153365B1 (ko) *	2018-03-19	2020-09-08	주식회사 옵티팜	신규한 바이러스 유사입자, 이를 포함하는 돼지 써코바이러스 3에 의한 질환에 대한 백신 조성물, 및 이의 제조 방법
CN114341191A (zh) *	2019-08-20	2022-04-12	Km生物医药股份公司	猪圆环病毒2型vlp疫苗
BR102019017792A2 (pt) *	2019-08-27	2021-11-16	Fundação Oswaldo Cruz	Receptáculo proteico, método para produção do receptáculo, método de identificação de patógenos ou de diagnóstico de doenças, e, uso do receptáculo
EP4225361A1 (en) *	2020-10-05	2023-08-16	Boehringer Ingelheim Animal Health USA Inc.	Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5202430A (en) *	1990-01-16	1993-04-13	University Of Tennessee	Transmissible gastroenteritis virus genes
US5565205A (en) *	1990-08-16	1996-10-15	Solvay Animal Health, Inc.	Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
GB9023111D0 (en) *	1990-10-24	1990-12-05	Wellcome Found	Expression system
CA2094515C (en) *	1990-11-01	1998-09-01	Theodore T. Kramer	Bacterial attenuation method and vaccine
US5580557A (en) *	1991-10-09	1996-12-03	Iowa State University Research Foundation, Inc.	Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals
US5338543A (en) *	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5885823A (en) *	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
ATE199022T1 (de) *	1996-10-09	2001-02-15	Akzo Nobel Nv	Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des sweins (prrsv)
US5735555A (en) *	1996-12-18	1998-04-07	Siemens Automotive Corporation	Fuel rail to fuel tube end compact connector
FR2781159B1 (fr) *	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
US20060029617A1 (en) *	1997-10-03	2006-02-09	Charreyre Catherine E	Porcine circovirus and Helicobacter combination vaccines and methods of use
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US7192594B2 (en) *	1997-10-03	2007-03-20	Merial Limited	Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6517843B1 (en) *	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6391314B1 (en) *	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
US7211379B2 (en) *	1997-10-03	2007-05-01	Merial Sas	Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US20040062775A1 (en) *	1997-12-05	2004-04-01	Agence Francaise De Securite Sanitaire Des Aliments	Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
CN1309708A (zh) *	1997-12-11	2001-08-22	萨斯喀彻温大学	来源于猪的断奶后多系统消耗综合症病毒
WO1999045956A1 (en) *	1998-03-13	1999-09-16	University Of Georgia Research Foundation, Inc.	Vaccines against circovirus infections
US6294176B1 (en) *	1998-07-10	2001-09-25	Schering-Plough Veterinary Corp.	Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
FR2789695B1 (fr) *	1999-02-11	2003-03-07	Merial Sas	Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en) *	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
US6497883B1 (en) *	1999-06-10	2002-12-24	Merial	Porcine circovirus recombinant poxvirus vaccine
US6808900B2 (en) *	2000-06-15	2004-10-26	Manitoba, University Of	Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
US7018638B2 (en) *	2000-12-19	2006-03-28	Wyeth	Mycoplasma hyopneumoniae bacterin vaccine
ATE430807T1 (de) *	2001-03-27	2009-05-15	Univ Saskatchewan	Verfahren zur kultivierung von circovirus
US20030096377A1 (en) *	2001-06-28	2003-05-22	Virginia Tech Intellectual Properties, Inc.	Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
KR20040030785A (ko) *	2001-07-02	2004-04-09	화이자 프로덕츠 인크.	마이코플라즈마 하이오뉴모니애로의 1회 투여량 예방접종
US7361352B2 (en) *	2001-08-15	2008-04-22	Acambis, Inc.	Influenza immunogen and vaccine
US7276353B2 (en) *	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) *	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US6841364B2 (en) *	2002-01-22	2005-01-11	Protatek International, Inc.	Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
US20030215455A1 (en) *	2002-05-14	2003-11-20	Bailey Reynolds	Vaccine stabilizer and method of use
US7223207B1 (en) *	2002-09-13	2007-05-29	Simon Basyuk	Exercise and massage device
CN1458167A (zh) *	2003-06-02	2003-11-26	中国农业科学院哈尔滨兽医研究所	截短表达的猪圆环病毒ⅱ型衣壳蛋白抗原及其应用
US7335361B2 (en) *	2003-06-09	2008-02-26	Animal Technology Institute Taiwan	Fusion antigen used as vaccine
PL1651265T3 (pl) *	2003-07-24	2008-10-31	Merial Ltd	Formulacje szczepionek zawierających emulsję olej w wodzie
PT1651260E (pt) *	2003-07-25	2009-09-24	Boehringer Ingelheim Vetmed	Lawsonia intracellularis de origem europeia e vacinas, agentes de diagnóstico e métodos para sua utilização
FR2861731B1 (fr) *	2003-10-30	2006-02-24	Centre Nat Rech Scient	Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
CN1579553A (zh) *	2004-05-18	2005-02-16	浙江大学	Ii型猪圆环病毒核酸疫苗的制备方法及其应用
WO2006068663A2 (en) *	2004-06-30	2006-06-29	Id Biomedical Corporation Of Quebec	Vaccine compositions for treating coronavirus infection
US7833707B2 (en) *	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) *	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
BRPI0606539A2 (pt) *	2005-01-13	2009-06-30	Boehringer Ingelheim Vetmedica Gmbh	vacinas aperfeiçoadas contra a prrs
US7300785B2 (en) *	2005-02-03	2007-11-27	Universiteit Ghent	Culturing circular ssDNA viruses for the production of vaccines
US8834891B2 (en) *	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
HRP20161132T1 (hr) *	2005-04-13	2016-12-02	Merial, Inc.	Postupak proizvodnje svinjskog cirkovirusa
US7691368B2 (en) *	2005-04-15	2010-04-06	Merial Limited	Vaccine formulations
EP3868400A1 (en) *	2005-12-29	2021-08-25	Boehringer Ingelheim Animal Health USA Inc.	Multivalent pcv2 immunogenic compositions and methods of producing such compositions
DK2371383T3 (en) *	2005-12-29	2015-11-30	Boehringer Ingelheim Vetmed	Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs
EP2099927A4 (en) *	2006-11-22	2010-05-05	Boehringer Ingelheim Vetmed	Methods of reducing porcine circovirus-associated disease outbreaks
US20090017064A1 (en) *	2007-07-10	2009-01-15	Wyeth	Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) *	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
CA2710558A1 (en) *	2007-12-31	2009-07-16	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 orf2 virus like particle with foreign amino acid insertion

2008
- 2008-12-31 CA CA 2710558 patent/CA2710558A1/en not_active Abandoned
- 2008-12-31 BR BRPI0821456-5A patent/BRPI0821456A2/pt not_active IP Right Cessation
- 2008-12-31 KR KR1020107014080A patent/KR20100103535A/ko not_active Ceased
- 2008-12-31 AU AU2008347235A patent/AU2008347235A1/en not_active Abandoned
- 2008-12-31 WO PCT/US2008/088678 patent/WO2009088950A2/en active Application Filing
- 2008-12-31 JP JP2010540954A patent/JP2011508595A/ja active Pending
- 2008-12-31 EP EP20080869827 patent/EP2231182A4/en not_active Withdrawn
- 2008-12-31 CN CN200880126037.1A patent/CN101932336B/zh not_active Expired - Fee Related
- 2008-12-31 US US12/812,590 patent/US20110020394A1/en not_active Abandoned
2015
- 2015-01-08 US US14/592,562 patent/US20150202282A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20100103535A (ko)	2010-09-27
CN101932336B (zh)	2014-07-09
CA2710558A1 (en)	2009-07-16
WO2009088950A2 (en)	2009-07-16
EP2231182A2 (en)	2010-09-29
CN101932336A (zh)	2010-12-29
JP2011508595A (ja)	2011-03-17
WO2009088950A3 (en)	2009-10-08
US20110020394A1 (en)	2011-01-27
US20150202282A1 (en)	2015-07-23
EP2231182A4 (en)	2012-08-22
AU2008347235A1 (en)	2009-07-16

Publication	Publication Date	Title
EP2144600A4 (en)	2011-03-16	POLY (AMINIC ACID) TARGET MOLECULES
EP2285931A4 (en)	2014-11-19	COOLANT COMPOSITION
EP2381760A4 (en)	2013-01-16	CORN PROTEIN COMPOSITION
EP2340324A4 (en)	2012-12-12	ELECTROSTATIC WIRING ASSEMBLY
DK2373293T3 (da)	2013-10-07	Sammensætninger med reduceret dimerdannelse
BRPI0908817A2 (pt)	2015-07-28	Montagem inseridora
BRPI0906749A2 (pt)	2015-07-07	Composição
BRPI0913808A2 (pt)	2017-06-20	composição
EP2251403A4 (en)	2011-11-09	CLEANING SUPPLIES
BRPI0922181A2 (pt)	2016-11-01	partículas de anti-corrosivo
EP2406364A4 (en)	2012-07-25	CLEANING SUPPLIES
BRPI0917231A2 (pt)	2015-11-10	composição
BRPI0919255A2 (pt)	2015-12-15	aparelho de limpeza de ar
IL212797A0 (en)	2011-07-31	Flat field eyepiece
EP2275414A4 (en)	2011-12-28	Cyclopentylacrylic acid amide derivative
BRPI0818118A2 (pt)	2015-08-04	Suspensão pediátrica estabilizada de carisbamato
BRPI0917982A2 (pt)	2015-11-17	composição de alvejamento particulada que compreende enzimas
FI20086143A0 (fi)	2008-11-28	Pistorasia
FR2926681B1 (fr)	2015-12-11	Connecteur
BRPI0821456A2 (pt)	2015-06-16	Partícula similar à pcv2 orf2 com inserção de aminoácido estranho
BRPI1010198A2 (pt)	2016-03-29	composição de poliamida modificada
BRPI0910795A2 (pt)	2015-09-29	formulações apresentando compatibilidade aperfeiçoada com substratos não tecidos
EP2380582A4 (en)	2012-08-01	LOW-CONCENTRATED NUTRITIONAL COMPOSITION
EP2357204A4 (en)	2012-06-27	COMPOSITION
EP2358870A4 (en)	2012-05-30	PLANT WITH CHANGED FLOWER LEVEL

Legal Events

Date	Code	Title	Description
2015-11-24	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2016-03-29	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.